tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Bruce Jackson, 201 are a BUY (91.78%), 18 are a HOLD (8.22%).
Analyst Bruce Jackson, currently employed at BENCHMARK, carries an average stock price target met ratio of 45.99% that have a potential upside of 34.15% achieved within 214 days.
Bruce Jackson’s has documented 387 price targets and ratings displayed on 32 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on UNCY, Unicycive Therapeutics at 20-Aug-2026.
Analyst best performing recommendations are on GNLX (GENELUX COMMON STOCK).
The best stock recommendation documented was for BFRI (BIOFRONTERA) at 12/15/2021. The price target of $220 was fulfilled within 6 days with a profit of $81 (58.27%) receiving and performance score of 97.12.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 22-Jul-2021
$7.5
5 years 2 months 12 days ago
(22-Jul-2021)
2/2 (100%)
$2.76 (58.23%)
256
Hold Since 03-Dec-2020
$10
$9.54 (2073.91%)
$8
5 years 10 months 1 days ago
(03-Dec-2020)
0/3 (0%)
$2.49 (33.16%)
Hold Since 17-Jun-2020
$7
6 years 3 months 17 days ago
(17-Jun-2020)
2/2 (100%)
$-0.16 (-2.23%)
151
Buy Since 26-May-2020
$4
$3.54 (769.57%)
$21
6 years 3 months 17 days ago
(17-Jun-2020)
1/2 (50%)
$0.11 (2.83%)
15
Buy Since 04-Jan-2019
$9
6 years 9 months 18 days ago
(16-Dec-2019)
2/2 (100%)
$4.61 (105.01%)
309
Which stock is Bruce Jackson most bullish on?
Which stock is Bruce Jackson most reserved on?
What Year was the first public recommendation made by Bruce Jackson?
